Outcome of paediatric domiciliary mask ventilation in neuromuscular and skeletal disease

Eur Respir J. 2000 Sep;16(3):476-81. doi: 10.1034/j.1399-3003.2000.016003476.x.

Abstract

Noninvasive positive pressure ventilation delivered by nasal mask or facemask has been used widely in the last decade to manage chronic ventilatory failure in adults with neuromuscular and chest wall disease. However, it has been thought that paediatric patients would not be able to tolerate masks, and previous anecdotal reports on the paediatric application of mask ventilation have not assessed the effects on nocturnal and arterial blood gas control. Domiciliary mask ventilation has been used in 40 children with ventilatory insufficiency due to congenital neuromuscular and skeletal disease aged 9 months-16 yrs. Eighteen patients had symptomatic nocturnal hypoventilation, 17 had diurnal ventilatory failure, three were referred for weaning and two had frequent chest infections associated with sleep-disordered breathing. Thirty eight of the 40 patients tolerated mask ventilatory support long-term. Diurnal mean+/-SD oxygen tension in arterial blood (Pa,O2) increased from 8.5+/-1.8-10.9+/-1.7 kPa (p<0.001) and mean carbon dioxide tension in arterial blood (Pa,CO2) fell from 7.0+/-1.6-5.9+/-0.8 kPa (p=0.01) following initiation of ventilatory support. Mean and minimum nocturnal Pa,O2 and peak transcutaneous carbon dioxide tension (Ptc,CO2) (n=21) improved significantly. Mask ventilation can be used successfully in young children and reverses ventilatory insufficiency due to congenital neuromuscular and skeletal disease.

MeSH terms

  • Adolescent
  • Bone Diseases / complications*
  • Bone Diseases / congenital
  • Carbon Dioxide / blood
  • Child
  • Child, Preschool
  • Follow-Up Studies
  • Home Nursing
  • Humans
  • Infant
  • Masks*
  • Neuromuscular Diseases / complications*
  • Neuromuscular Diseases / congenital
  • Oxygen / blood
  • Partial Pressure
  • Positive-Pressure Respiration / instrumentation*
  • Respiratory Insufficiency / etiology
  • Respiratory Insufficiency / therapy*
  • Treatment Outcome

Substances

  • Carbon Dioxide
  • Oxygen